GGrantIndex
← Leaderboards

Joe Brice Weinberg

Duke University

$9,293,887
Attributed
$10,043,356
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $785.3K · FY200518
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$10,043,356 · 6
VA$0 · 2

By mechanism

R01$9,140,557 · 3
R21$490,014 · 1
P50$213,610 · 1
R34$199,175 · 1
I01$0 · 2

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Nitric Oxide

Research focus

Nitric OxideNitric Oxide SynthaseProductionTissuesMalariaIn VivoCellsLeadIn VitroPlasmodium FalciparumAdultResponseFunctional DisorderChildHuman SubjectGrowthCessation Of LifeGenetic PolymorphismDrug KineticsArginineIntravenousBiological AvailabilityClinical ResearchPathogenesis

Grant awards (33)

Nitric Oxide and Microvascular Dysfunction in Severe Malaria$342,069
R01 · FY2018 · HL · contact PI
Nitric Oxide and Microvascular Dysfunction in Severe Malaria$59,999
R01 · FY2018 · HL · contact PI
Combining gene therapy and tissue engineering to enhance meniscal repair$0
I01 · FY2018 · VA · contact PI
Nitric Oxide and Microvascular Dysfunction in Severe Malaria$345,004
R01 · FY2017 · HL · contact PI
Combining gene therapy and tissue engineering to enhance meniscal repair$0
I01 · FY2017 · VA · contact PI
Nitric Oxide and Microvascular Dysfunction in Severe Malaria$351,290
R01 · FY2016 · HL · contact PI
Combining gene therapy and tissue engineering to enhance meniscal repair$0
I01 · FY2016 · VA · contact PI
Nitric Oxide and Microvascular Dysfunction in Severe Malaria$367,910
R01 · FY2015 · HL · contact PI
Combining gene therapy and tissue engineering to enhance meniscal repair$0
I01 · FY2015 · VA · contact PI
Biologic Scaffold Prostheses to Enhance Meniscus Repair$0
I01 · FY2014 · VA · contact PI
Biologic Scaffold Prostheses to Enhance Meniscus Repair$0
I01 · FY2014 · VA · contact PI
Biologic Scaffold Prostheses to Enhance Meniscus Repair$0
I01 · FY2014 · VA · contact PI
Arginine, Nitric Oxide, and Severe Malaria$569,383
R01 · FY2012 · AI · contact PI
Nitric Oxide and Malaria$199,175
R34 · FY2012 · AI · contact PI
Arginine, Nitric Oxide, and Severe Malaria$569,398
R01 · FY2011 · AI · contact PI
Arginine, Nitric Oxide, and Severe Malaria$580,115
R01 · FY2010 · AI · contact PI
Arginine, Nitric Oxide, and Severe Malaria$571,594
R01 · FY2009 · AI · contact PI
Biologic scaffold prostheses to enhance meniscus repair$0
I01 · FY2009 · VA · contact PI
Arginine, Nitric Oxide, and Severe Malaria$603,941
R01 · FY2008 · AI · contact PI
Nitric Oxide and Severe Malaria$503,672
R01 · FY2007 · AI · contact PI
Nitric Oxide and Severe Malaria$513,032
R01 · FY2006 · AI · contact PI
Nitric Oxide and Severe Malaria$519,730
R01 · FY2005 · AI
Inducible NOS as a Treatment Target in CLL$265,600
R01 · FY2005 · CA
Nitric Oxide and Severe Malaria$514,245
R01 · FY2004 · AI
Inducible NOS as a Treatment Target in CLL$265,600
R01 · FY2004 · CA
Nitric Oxide and Severe Malaria$388,951
R01 · FY2003 · AI
Inducible NOS as a Treatment Target in CLL$265,600
R01 · FY2003 · CA
Nitric Oxide and Severe Malaria$490,014
R21 · FY2002 · AI
Inducible NOS as a Treatment Target in CLL$265,600
R01 · FY2002 · CA
NITRIC OXIDE AND SEVERE MALARIA$513,435
R01 · FY2001 · AI
Inducible NOS as a Treatment Target in CLL$265,600
R01 · FY2001 · CA
NITRIC OXIDE AND SEVERE MALARIA$498,789
R01 · FY2000 · AI
NITRIC OXIDE AND RHEUMATOID ARTHRITIS$213,610
P50 · FY2000 · AR